Clinical Trials e-Newsletter

Clinical Trials e-Newsletter | March 2020

Updates on Clinical Trials

AMG 160 Clinical Trial

A study to evaluate the efficacy of AMG 160 in combination with pembrolizumab in adult subjects with metastatic castration-resistant prostate cancer (mCRPC).

View Patient Summary

Keynote 641

A clinical trial for men with metastatic castration-resistant prostate cancer (mCRPC) to study if combining pembrolizumab and enzalutamide can slow down prostate cancer .

View Patient Summary

Keynote 921

A clinical trial is for men with metastatic castration-resistant prostate cancer (mCRPC) who have not received chemotherapy, and failed prior treatment with enzalutamide, abiraterone, and apalutamide.

View Patient Summary

Keylynk 010

This clinical trial is for men who have metastatic castration resistant prostate cancer (mCRPC) and failed to respond abiraterone acetate or enzalutamide (but not both) and to chemotherapy

View Patient Summary

More Trials

Find Your Trial (FYT) Tool

Find A Trial That Fits

Your Needs

Click on the link below that defines where you are on your prostate cancer journey and PHEN's "Find Your Trial (FYT) Tool" will present you with a listing of available clinical trials.

Patients with Low and Intermediate Risk Prostate Cancer

High Risk Prostate Cancer Patients

Patients Treated with Prostatectomy or Radiation

Patients with Recurrent Prostate Cancer

Patients with Castration Resistant Prostate Cancer (CRPC)

Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients

Understanding Castration Resistant Prostate Cancer

Androgen deprivation (hormone) therapy, such as Lupron, works to reduce testosterone in the body to castration levels to prevent or slow the progression of prostate cancer.

What is Castration resistant Prostate Cancer?

Prostate cancer becomes Castration Resistant when the cancer progresses despite treatment with anti-androgen therapy.

What is non-Metastatic Castration Resistant Prostate Cancer?

Castration Resistant Prostate Cancer where no metastases have been detected.

What is Metastatic Castration Resistant Prostate Cancer?

Castration Resistant Prostate Cancer that has spread and metastasized to other parts of the body such as bones and other organs.